Lab-on-a-chip may help identify new treatments for liver disease
Non-alcoholic fatty liver disease (NAFLD)—the accumulation of liver fat in people who drink little or no alcohol—is increasingly common around the world, and in the United States, it affects between 30 and 40 percent ...
Aug 29, 2019
0
1
